Prognosis of patients with locally advanced squamous cell carcinoma of the head and neck: Impact of tumor cell expression of EPO and EPO-R

Strahlentherapie und Onkologie

Volumn 189, Issue 7, 2013, Pages 559-565

  Seibold, N D ^a   Schild, S E ^b   Gebhard, M P ^a   Noack, F ^a   Rades, D ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Erythropoietin; Head and neck neoplasms; Radiotherapy; Receptors; Treatment outcome

Indexed keywords

CISPLATIN; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; FLUOROURACIL; HEMOGLOBIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOHISTOCHEMISTRY; LARYNX CANCER; LOCOREGIONAL CONTROL; MAJOR CLINICAL STUDY; MALE; METASTASIS FREE SURVIVAL; MULTIMODALITY CANCER THERAPY; OROPHARYNX CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PROTEIN EXPRESSION; RADIATION DOSE; RETROSPECTIVE STUDY; TUMOR CELL; TUMOR LOCALIZATION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; ERYTHROPOIETIN; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; LARYNX; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; OROPHARYNGEAL NEOPLASMS; OROPHARYNX; PROGNOSIS; RECEPTORS, ERYTHROPOIETIN; SURVIVAL RATE;

EID: 84879912650     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-013-0320-7     Document Type: Article

References (23)

1. Acs G, Xu X, Chu C et al (2004) Prognostic significance of erythropoietin expression in human endometrial carcinoma. Cancer 100:2376-2386 (Pubitemid 38657885)
2. Acs G, Zhang PJ, McGrath CM et al (2003) Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression. Am J Pathol 162:1789-1806 (Pubitemid 36613038)
3. Acs G, Zhang PJ, Rebbeck TR et al (2002) Immunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinoma. Cancer 95:969-981 (Pubitemid 34925345)
4. Arcasoy MO, Amin K, Chou SC et al (2005) Erythropoietin and erythropoietin receptor expression in head and neck cancer: relationship to tumor hypoxia. Clin Cancer Res 11:20-27 (Pubitemid 40075774)
5. Batra S, Perelman N, Luck RL et al (2003) Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival. Lab Invest 83:1477-1487 (Pubitemid 37267831)
6. Becker A, Stadler P, Lavey RS et al (2000) Severe anemia is associated with poor tumor oxygenation in head and neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 46:459-466 (Pubitemid 30067797)
7. Cerezo L, Millan I, Torre A et al (1992) Prognostic factors for survival and tumor control in cervical lymph node metastases from head and neck cancer. A multivariate study of 492 cases. Cancer 69:1224-1234
8. Cvek J, Kubes J, Skacelikova E et al (2012) Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study. Strahlenther Onkol 188:666-670
9. Denis F, Garaud P, Bardet E et al (2004) Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 22:69-76 (Pubitemid 41095116)
10. Due AK, Vogelius IR, Aznar MC et al (2012) Methods for estimating the site of origin of locoregional recurrence om head and neck squamous cell carcinoma. Strahlenther Onkol 188:671-676
11. Henke M, Mattern D, Pepe M et al (2006) Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol 24:4708-4713 (Pubitemid 46630934)
12. Jeremic B, Milicic B (2008) Pretreatment prognostic factors of local recurrence-free survival in locally advanced squamous cell carcinoma of the head and neck treated with radiation therapy with or without concurrent chemotherapy. Am J Clin Oncol 31:213-218
13. Kaplan EL, Meier P (1958) Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481
14. Li HG, Li JS, Chen WL et al (2009) Prognostic significance of erythropoietin and erythropoietin receptor in tongue squamous cell carcinoma. Br J Oral Maxillofac Surg 47:470-475
15. Lin YT, Chuang HC, Chen CH et al (2012) Clinical significance of erythropoietin receptor expression in oral squamous cell carcinoma. BMC Cancer 12:194
16. McBroom JW, Acs G, Rose GS et al (2005) Erythropoietin receptor function and expression in epithelial ovarian carcinoma. Gynecol Oncol 99:571-577 (Pubitemid 41686538)
17. Nguyen NP, Vock J, Chi A et al (2012) Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer. Strahlenther Onkol 188:677-685
18. Petersen I, Schewe C, Schlüns K et al (2007) Inter-laboratory validation of PCR-based HPV detection in pathology specimens. Virchows Arch 451:701-716 (Pubitemid 47340979)
19. Rades D, Golke H, Schild SE, Kilic E (2008) The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation. Int J Radiat Oncol Biol Phys 71:152-159 (Pubitemid 351491394)
20. Rades D, Seibold ND, Gebhard MP et al (2011) Prognostic factors (including HPV status) for irradiation of locally advanced squamous cell carcinoma of the head and neck (SCCHN). Strahlenther Onkol 187:626-632
21. Rades D, Setter C, Dahl O et al (2011) Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 80:499-505
22. Rades D, Stoehr M, Kazic N et al (2008) Locally advanced stage IV squamous cell carcinoma of the head and neck: impact of pre-radiotherapy hemoglobin level and interruptions during radiotherapy. Int J Radiat Oncol Biol Phys 70:1108-1114 (Pubitemid 351296118)
23. Wentzensen N, Knebel-Doeberitz M (2004) Viral cancerogenesis of head and neck tumors. Pathologe 25:21-30 (Pubitemid 38235205)